When was LifeCell founded?

LifeCell was founded in 2004 and raised its 1st funding round 2 years after it was founded.

Where is LifeCell located?

LifeCell is headquartered in Chennai, India. It is registered at No.16,Vijayaraghava Road, I Lane, T Nagar, Chennai, Chennai, Tamil Nadu, India, 600017.

Which legal entities is LifeCell associated with?

LifeCell is associated with LIFECELL INTERNATIONAL PRIVATE LIMITED and 1 other.

How many employees does LifeCell have?

As of Aug 31, 2025, the latest employee count at LifeCell is 1210.

Is LifeCell a funded company?

LifeCell is a funded company, having raised a total of $61.2M across 5 funding rounds to date. The company's 1st funding round was a $***** Angel round, raised on Dec 14, 2006.

How much is LifeCell worth?

The latest valuation of LifeCell is $***** as of Mar 28, 2024.

When was the latest funding round of LifeCell?

LifeCell's latest funding was a $***** Series B round on Mar 28, 2024, with participation from 4 investors.

What is the annual revenue of LifeCell?

Annual revenue of LifeCell is between ₹500 Cr and ₹1,000 Cr as on Mar 31, 2025

Where does LifeCell rank among its competitors?

LifeCell ranks 3rd amongst 162 active competitors, of which 25 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Turbine, which secured $25M in Feb, 2026.

Who are the top competitors of LifeCell?

LifeCell's top competitors include Natera, Cordlife and Lantern Pharma. Among them, Turbine secured the most recent funding round in February, 2026.

LifeCell - 2026 Company Profile, Team, Funding, Competitors & Financials

LifeCell is a series B company based in Chennai (India), founded in 2004. It operates as an A stem cell banking company specializing in cord blood and tissue preservation. LifeCell has raised $61.2M in funding from investors like Orbimed, Helion Venture Partners and Brand Capital, with a current valuation of $*****. The company has 162 active competitors, including 25 funded and 28 that have exited. Its top competitors include companies like Natera, Cordlife and Lantern Pharma.

Company Details

A stem cell banking company specializing in cord blood and tissue preservation. The company provides stem cell banking services focused on preserving umbilical cord blood and tissue stem cells for potential future medical treatments. It also offers lab tests, allografts, and skincare products through its platform.

Website: www.lifecell.in/
Social
Email ID: *****@lifecell.in
Phone Number: +91 **********
Registered Address: No.16,Vijayaraghava Road, I Lane, T Nagar, Chennai, Chennai, Tamil Nadu, India, 600017

Key Metrics

Founded Year

2004

Location

Chennai, India

Stage

Series B

Total Funding

$61.2M in 5 rounds

Latest Funding Round

Series B, Mar 28, 2024, $*****

Post Money Valuation

$***** as on Mar 28, 2024

Investors

Orbimed & 75 more

Ranked

3^rd among 162 active competitors

Annual Revenue

₹500 - ₹1,000 Cr as on Mar 31, 2025

Employee Count

1,210 as on Aug 31, 2025

Investment & Acquisitions

Strides Arcolab & 2 more

Similar Companies

Natera & 206 more

View LifeCell's full profile

LifeCell is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
LIFECELL INTERNATIONAL PRIVATE LIMITED CIN: U85196TN2004PTC053577 , India, Active	Jun 28, 2004	₹500 - ₹1,000 Cr (As on Mar 31, 2025)	1671 (As on Apr 01, 2026)
NAVARATAN CONSTRUCTION & INVESTMENT PRIVATE LIMITED CIN: U50100TN2013PTC091766 , India, Active	Jun 20, 2013	0 - ₹10 Cr (As on Mar 31, 2025)	144 (As on Mar 31, 2020)

LifeCell has raised a total funding of $61.2M over 5 rounds. Its first funding round was on Dec 14, 2006. Its latest funding round was a Series B round on Mar 28, 2024 for $*****. 4 investors participated in its latest round. LifeCell has 9 institutional investors and 67 angel investors.

Here is the list of recent funding rounds of LifeCell:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 28, 2024	2445697	Series B	5328877	7703755	9692772	9549262
Sep 21, 2021	5462206	Series B	9756197	7920760	3559538	5479576
Feb 22, 2013	7996310	Series A	8621733	6413190	Helion Venture Partners	4137228

Access funding benchmarks and valuations. Sign up today!

View details of LifeCell's funding rounds and investors

LifeCell's Board of Directors

LifeCell's board has 4 active members. Abhaya Mayur is part of team and Sunny Sharma, Sumona Chakraborty and Abhayakumar Deepak are independent board members.

Here is the list of LifeCell's board of directors:

Name	Type	Representing	Status	Duration
olakisl	Team	-	Current	1y 9m
Sunny Sharma	Independent board member	-	Current	4y 9m
oxd{zbz	Independent board member	-	Current	7y 4m
oshsakq	Independent board member	-	Current	3y 7m

LifeCell's employee count trend

LifeCell has 1,210 employees as of Aug 25. The total employee count is 14.0% more than what it was in Aug 24. Here is LifeCell's employee count trend over the years:

Uncover LifeCell's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of LifeCell include Natera, Cordlife and Lantern Pharma. Here is the list of Top 10 competitors of LifeCell, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Natera 2004, Redwood City (United States), Public	Developer of cell-free DNA testing for oncology, women’s health, and organ health	$152M	Harmony Partners, Foresite Capital & 17 others	77/100
2nd	Cordlife 2001, Singapore (Singapore), Public	Provider of cord blood and cord lining banking and newborn metabolic screening	$7M	UOB, APC Investors & 2 others	69/100
3rd	LifeCell 2004, Chennai (India), Series B	A stem cell banking company specializing in cord blood and tissue preservation	$61.2M	Helion Venture Partners, Orbimed & 74 others	65/100
4th	Lantern Pharma 2013, Dallas (United States), Public	Developing drug and companion diagnostics for multi-drug resistant cancers	$7.12M	Green Park & Golf Ventures, Bios Partners ... & 3 others	62/100
5th	GeneDx 2000, Gaithersburg (United States), Acquired	Provider of genetic testing for inherited disorders	-	Oak HC/FT, S32 & 1 others	62/100
6th	Strata Oncology 2015, Ann Arbor (United States), Series C	Precision oncology company enabling smarter cancer treatment through advanced biomarker algorithms	$139M	Merck Global Health Innovation Fund, Wellington ... & 8 others	62/100
7th	Nucleus Genomics 2021, Manhattan (United States), Series A	Provider of genetic testing kits for rare variant analysis	$32M	Founders Fund, Kube VC & 26 others	62/100
8th	Turbine 2015, Budapest (Hungary), Series B	Provider of an AI based cancer therapy management software for researchers and doctors	$61.7M	Accel, Merck Global Health Innovation Fund ... & 19 others	59/100
9th	ArcherDX 2013, Boulder (United States), Acquired	Developer of molecular cancer diagnostic products	$153M	Perceptive Advisors, PBM Capital & 8 others	58/100
10th	RareCyte 2009, Seattle (United States), Series C	Developer of technologies for the analysis of rare and single cells in the blood	$114M	Arboretum Ventures, F-Prime Capital & 11 others	57/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on LifeCell's competitors? Click here to see the top ones

Founders own 23.04%, Funds (largest shareholder) own 48.28%, Enterprises own 12.49% and Angels own 0.30%. The net worth of LifeCell's founders is INR 200Cr as of Mar 28, 2024.

Shareholders Name	Post Round Holding %	Net worth	Cumulative Investment	Realised Returns	Unrealised Returns	Return Multiple
Founder	23.04%	200Cr	7819979	7194219	3431183	5327877
Fund	48.28%	420Cr	1676617	3804177	4362425	9358079
Orbimed	7815326	7882968	7329469	5254194	8721754	3093238
Brand Capital	0	0	0	0	0	0
Enterprise	12.49%	109Cr	8515081	7141051	7618505	2907310
Angel	0.30%	2.64Cr	0	0	0	0
Ishab Singhvi	0	0	0	0	0	0
Panemangalore Surendra Pai	0	0	0	0	0	0
Other People	12.77%	111Cr	1374004	4250262	8399274	4829153
ESOP Pool	3.12%	27.1Cr	925	917	792	526
Total	100.00%	870Cr	8129700	6281849	4575229	8747771

To unlock detailed Cap Table of LifeCell Sign up today!

Notes: The column Net Worth represents the net worth of investments made by that entity, as per the latest cap table.

Disclaimer

View more details of LifeCell's Shareholding

LifeCell has made 2 investments in Strides Arcolab and Mfine and acquired FetoMed.

Here is the list of these investments and acquisitions:

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Sep 07, 2018	Investments	Strides Arcolab	1990	Bengaluru (India)
Aug 18, 2017	Investments	Mfine	2017	Bengaluru (India)
May 09, 2016	Acquisition	FetoMed	2013	Chennai (India)